Glucose Measurements Don't Improve Cardiovascular Risk Assessment, JAMA Reveals

Published: Mar 26, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Although blood glucose and glycated hemoglobin (HbA1c) play a central role in diabetes, the value of these measurements to assess cardiovascular risk has been unclear. Now, in a paper published in JAMA, members of the Emerging Risk Factors Collaboration analyze data from nearly 300,000 people without known diabetes or cardiovascular disease who were enrolled in 73 prospective studies.

Hey, check out all the engineering jobs. Post your resume today!

Back to news